Mochida Pharmaceutical Co., Ltd. (TYO:4534)
Japan · Delayed Price · Currency is JPY 3,110.00
-70.00 (-2.20%)
Aug 4, 2026, 11:25 AM JST
Mochida Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 112,637 | 122,656 | 112,734 | 114,243 | 116,879 | 141,444 | |
Market Cap Growth | -1.63% | 8.80% | -1.32% | -2.25% | -17.37% | -13.85% |
Enterprise Value | 94,230 | 91,159 | 59,153 | 70,835 | 57,234 | 80,242 |
Last Close Price | 3180.00 | 3460.00 | 3107.40 | 3074.34 | 3113.67 | 3398.55 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.26 | 15.52 | 19.83 | 25.13 | 17.58 | 13.38 |
Forward PE | - | 18.59 | 18.59 | 20.70 | 18.73 | 15.31 |
PS Ratio | 0.96 | 1.05 | 1.07 | 1.11 | 1.13 | 1.28 |
PB Ratio | 0.80 | 0.87 | 0.86 | 0.89 | 0.92 | 1.10 |
P/TBV Ratio | 0.81 | 0.88 | 0.87 | 0.90 | 0.93 | 1.11 |
P/FCF Ratio | - | - | 15.67 | - | 22.78 | 31.64 |
P/OCF Ratio | - | - | 12.05 | - | 16.02 | 18.96 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.81 | 0.78 | 0.56 | 0.69 | 0.55 | 0.73 |
EV/EBITDA Ratio | 6.77 | 6.94 | 5.35 | 8.23 | 5.12 | 4.70 |
EV/EBIT Ratio | 8.61 | 8.98 | 7.28 | 12.21 | 6.73 | 5.58 |
EV/FCF Ratio | - | - | 8.22 | - | 11.15 | 17.95 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.07 | 0.07 | - | - | - | - |
Debt / EBITDA Ratio | 0.76 | 0.76 | - | - | - | - |
Net Debt / Equity Ratio | -0.15 | -0.15 | -0.39 | -0.37 | -0.48 | -0.48 |
Net Debt / EBITDA Ratio | -1.60 | -1.60 | -4.62 | -5.43 | -5.41 | -3.62 |
Net Debt / FCF Ratio | 2.10 | 2.10 | -7.11 | 4.79 | -11.79 | -13.85 |
Asset Turnover | 0.68 | 0.68 | 0.66 | 0.65 | 0.64 | 0.68 |
Inventory Turnover | 1.75 | 1.75 | 1.62 | 1.86 | 2.03 | 2.21 |
Quick Ratio | 2.44 | 2.44 | 3.32 | 3.13 | 3.24 | 3.14 |
Current Ratio | 4.29 | 4.29 | 4.81 | 4.47 | 4.31 | 4.07 |
Return on Equity (ROE) | 5.83% | 5.83% | 4.40% | 3.57% | 5.21% | 8.27% |
Return on Assets (ROA) | 3.70% | 3.70% | 3.19% | 2.28% | 3.30% | 5.54% |
Return on Invested Capital (ROIC) | 6.38% | 7.22% | 7.14% | 5.81% | 9.41% | 16.01% |
Return on Capital Employed (ROCE) | 6.50% | 6.50% | 6.00% | 4.40% | 6.50% | 10.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 7.02% | 6.44% | 5.04% | 3.98% | 5.69% | 7.47% |
FCF Yield | -8.92% | -8.19% | 6.38% | -8.56% | 4.39% | 3.16% |
Dividend Yield | 2.72% | 2.31% | 2.57% | 2.60% | 2.57% | 2.65% |
Payout Ratio | 35.87% | 35.87% | 49.87% | 63.49% | 50.71% | 32.59% |
Buyback Yield / Dilution | 0.00% | 0.00% | 1.15% | 3.49% | 2.47% | 1.37% |
Total Shareholder Return | 2.73% | 2.31% | 3.72% | 6.09% | 5.04% | 4.02% |